Cushing Disease
📧 Sign up to get email alerts when something new happens for Cushing Disease.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2020-07-09FDA Approved: SIGNIFOR LAR — Supplemental Application (Recordati Rare Diseases, Inc.)
FDA approved a supplemental application for SIGNIFOR LAR (pasireotide) submitted by Recordati Rare Diseases, Inc., to modify the product lab…